or Try an Advanced Search...

    Generic Pharmaceutical Products Stocks List

    Symbol Grade Name % Change
    BLCO F Bausch + Lomb Corporation -1.88
    TEVA A Teva Pharmaceutical Industries -0.71
    View As Page of Charts
    Related Industries: Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
    Related Stock Lists: Active Pharmaceutical Ingredients Allergy Asthma Birth Control Blood Cells Bronchial Asthma Cancer Cataract Surgery Cataracts Chemical Entities Cholesterol Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Conjunctivitis Contact Lenses Contraception Drugs Fentanyl Fertility Generic Pharmaceutical

    Related ETFs - A few ETFs which own one or more of the above listed Generic Pharmaceutical Products stocks.

    Symbol Grade Name Weight
    ISRA D Market Vectors Israel ETF 9.1
    EIS C iShares MSCI Israel Capped Investable Market Index Fund 8.29
    PPH C Market Vectors Pharmaceutical ETF 2.68
    IZRL D ARK Israel Innovative Technology ETF 2.27
    MGMT C Ballast Small/Mid Cap ETF 1.7
    View all Generic Pharmaceutical Products ETFs...
    Compare ETFs
    Compare ISRA to IZRL Compare IZRL to MGMT Compare PPH to IZRL

        Generic Pharmaceutical Products Stocks Recent News

        Date Stock Title
        May 3 TEVA A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
        May 3 TEVA Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics
        May 2 TEVA Teva to Present at the 2024 Bank of America Healthcare Conference
        May 2 TEVA Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
        May 2 TEVA Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets
        May 2 TEVA Q1 2024 Corcept Therapeutics Inc Earnings Call
        May 2 TEVA Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
        May 1 BLCO Bausch + Lomb Corporation (BLCO) Q1 2024 Earnings Call Transcript
        May 1 BLCO Bausch & Lomb Corp (BLCO) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Net Loss Widening
        May 1 BLCO Bausch + Lomb GAAP EPS of -$0.48, revenue of $1.1B
        May 1 BLCO Bausch + Lomb Announces First-Quarter 2024 Results
        Apr 30 TEVA Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
        Apr 30 BLCO Bausch + Lomb Q1 2024 Earnings Preview
        Apr 30 TEVA U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
        Apr 29 BLCO Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
        Apr 29 BLCO Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Related Industries: Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
        Related Stock Lists: Active Pharmaceutical Ingredients Allergy Asthma Birth Control Blood Cells Bronchial Asthma Cancer Cataract Surgery Cataracts Chemical Entities Cholesterol Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Conjunctivitis Contact Lenses Contraception Drugs Fentanyl Fertility Generic Pharmaceutical
        Generic Pharmaceutical Products

        Browse All Tags